Atlas Venture
Venture capitalActively deployingCambridge · Seed–Late Stage · 14 people tracked
Investment thesis
Atlas Venture focuses on medical innovation, backing portfolio companies across therapeutics, medical devices, and healthcare technology sectors. The firm leverages three decades of industry experience and an internal incubator model to support early-stage companies from formation through successful exits.
Source: firm website, verified Jul 21, 2026.
Team · 14 people
from the firm's websiteWhat they invest in
from 21 of 62 portfolio companiesBiotech ×14Medical Devices ×9Deep Tech ×6AI & Machine Learning ×5Healthtech ×5Enterprise Software ×3Hardware ×2Advanced Manufacturing ×1
HQs:United States×15Azerbaijan×1
Investments · showing 60 of 62
founders shown can be your intro pathAntares Therapeutics discovers and develops precision medicines, with a focus on small molecule therapies targeting previously undruggable oncology targets and other serious diseases. The company combines proprietary chemistry, target biology, and predictive sciences to advance drug candidates for cancer and other therapeutic areas.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Adam Friedman(Chief Executive Officer)
Lifordi Immunotherapeutics develops treatments for immunology and rare diseases through discovery, clinical development, and commercialization. The company serves patients with immunological disorders and rare genetic conditions.
BiotechDeep TechHealthtech
Arthur O. Tzianabos, Ph.D.(President and CEO)Naina Bhasin, Ph.D.(Chief Business Officer)
nChroma Bio develops in vivo targeted delivery and genetic engineering technologies for genetic medicine applications. The company works with academic founders and institutional investors focused on advancing gene therapy treatments.
BiotechDeep TechMedical Devices
Luke Gilbert, PhDKeith Joung, MD, PhDDavid Liu, PhDAngelo Lombardo, PhD
Remix Therapeutics develops RNA reprogramming technology to treat various diseases and disorders. The company applies precision medicine approaches across oncology and other therapeutic areas.
AI & Machine LearningBiotechWatertown, US
Peter Smith, PhD(Co-Founder, President and Chief Executive Officer)Peter Smith(Co-Founder, President and Chief Executive Officer)
Affinia Therapeutics develops genetically engineered adeno-associated virus (AAV) therapies for treating genetic diseases, focusing initially on cardiovascular and central nervous system conditions. The company uses AI and structural modeling to redesign viral delivery vectors for one-time-dose genetic medicines across rare and prevalent diseases.
AI & Machine LearningBiotechDeep Tech
Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.
BiotechDigital HealthMedical Devices
Arkuda is an independent information platform that provides analysis and reviews of online gaming platforms operating in Azerbaijan, focusing on legal compliance, security protocols, and user protection for gaming platforms like Mostbet.
ConsumerGamingBaku, AZ
Verizon is a telecommunications company that provides wireless services and connectivity solutions to consumers and businesses. The company focuses on digital inclusion, workforce development, disaster resilience, and community programs.
Cloud ComputingEnterprise SoftwareNew York, US
DisplayLink develops USB graphics system-on-chip technology that enables multiple display expansion across Windows, macOS, ChromeOS, Ubuntu, and Android devices regardless of underlying hardware architecture. The company's chipsets power docking stations, USB monitors, adapters, and meeting room solutions for businesses and mobile device users seeking cross-platform productivity and IT cost optimization.
Enterprise SoftwareHardwareSemiconductors
Dyne Therapeutics develops targeted therapies for genetically driven neuromuscular diseases using its proprietary FORCE platform. The company focuses on discovery, clinical development, and commercialization of treatments for rare genetic disorders.
BiotechMedical DevicesWaltham, US
Earnest develops microbial seed coatings and agricultural biology products derived from prairie ecosystems to improve soil health and crop performance for farmers. The company has expanded from soil amendments to seed coatings that deliver biology directly on seeds, with plans to scale planter box treatments.
AgTechBiotech
Eddy Mejia(Founder)Dr. Gabe Price(Founder)
Stratasys develops polymer-based 3D printing technologies and solutions for product development across prototyping, tooling, and production. The company serves industries including aerospace, automotive, and healthcare with hardware, materials, and software for additive manufacturing.
Advanced ManufacturingDeep TechHardware
Grapevine operates a platform for Giving Circles that enables groups to pool donations, manage members, and direct funds to nonprofits. The platform serves collaborative giving communities seeking to amplify their philanthropic impact.
Impact & Social GoodSaaSSocial
Emily RasmussenJessan Hutchinson-QuillianChloe Moon
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
BiotechDeep TechHealthtech
Recorded Future provides cyberthreat intelligence and AI-powered cyber defense capabilities to help organizations identify and neutralize critical threats. The platform serves security teams and enterprises defending critical infrastructure worldwide.
AI & Machine LearningCybersecurityData & InfrastructureEnterprise Software
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.
BiotechDeep TechMedical Devices
Merck is a pharmaceutical company focused on developing medicines and vaccines for patients globally, guided by a science-led innovation strategy.
BiotechHealthtechMedical DevicesRahway, US
Johnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.
BiotechHealthtechMedical DevicesNew Brunswick, US
Akero develops engineered protein therapies for metabolic diseases, particularly MASH (metabolic dysfunction-associated steatohepatitis) and other conditions with high unmet medical need. The company's lead candidate, efruxifermin, is in phase 3 clinical trials for liver disease treatment.
BiotechHealthtechMedical Devices
An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.
AI & Machine LearningBiotechMedical Devices
Board seats · per SEC filings · 7
what is this? ⓘ$120.1M raise · filed Dec 2025 · via David Grayzel
$45M raise · filed Oct 2025 · via David Grayzel
$75M raise · filed Jan 2024 · via David Scott Grayzel
$5.4M raise · filed Aug 2021 · via Kristin Baker Spohn
$35M raise · filed Jun 2021 · via Kristin Baker Spohn
$95M raise · filed Feb 2021 · via David Grayzel
$75.8M raise · filed Aug 2020 · via David T. Grayzel
Inferred from directors named on each company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Atlas Venture invest at?
- Atlas Venture invests at the Seed, Series A, Series B, Late Stage stages.
- What sectors does Atlas Venture focus on?
- Atlas Venture focuses on Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is Atlas Venture located?
- Atlas Venture is headquartered in Cambridge, US.
Similar investors
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Khosla Ventures is a technology-focused investment firm that seeks companies leveraging disruptive technological advances to solve large-scale problems across multiple industries. The firm emphasizes proprietary technology, business model innovation, and early-stage, bold investments with unfair advantages.
A venture capital firm that supports founders developing transformative solutions across interconnected systems, with a particular focus on leveraging artificial intelligence and related technologies to advance health and human flourishing.
Apple Tree Partners is a life sciences venture capital firm that creates and builds transformative biotechnology companies from early-stage science through public markets. The firm works with scientists at various stages, from pre-IP ideas to company spinouts, providing capital, strategic guidance, and operational resources.